Yield10 Bioscience, Inc. Common Stock
YTEN
YTEN was delisted on the 15th of May, 2024.
13 hedge funds and large institutions have $9.28M invested in Yield10 Bioscience, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, reducing their positions, and 5 closing their positions.
19% less funds holding
Funds holding: 16 → 13 (-3)
22% less capital invested
Capital invested by funds: $11.9M → $9.28M (-$2.6M)
60% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 5
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $4K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FA
FCG Advisors
Chatham,
New Jersey
|
+$402K |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$201K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$134K |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$67K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$67K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Farm Mutual Automobile Insurance
Bloomington,
Illinois
|
-$2.9M |
| 2 |
GC
GMT Capital
Atlanta,
Georgia
|
-$255K |
| 3 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$201K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$79K |
| 5 |
AG
Aperio Group
Sausalito,
California
|
-$67K |
YTEN Hedge Fund Activity: Q4 2013 in Review
13 of the 3,446 institutional investors tracked by Wall St. Rank reported a position in Yield10 Bioscience, Inc. Common Stock (YTEN) for Q4 2013, worth a combined $9.28M — down 22% from $11.9M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of YTEN and 2 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 3 added.
The largest buyer was FCG Advisors, adding an estimated $402K. The largest seller was State Farm Mutual Automobile Insurance, exiting entirely with an estimated $2.9M sold.
- 13 institutional investors held Yield10 Bioscience, Inc. Common Stock (YTEN) as of Q4 2013, down from 16 in Q3 2013.
- Funds reported $9.28M of Yield10 Bioscience, Inc. Common Stock stock for Q4 2013, down 22% quarter-over-quarter.
- 2 funds opened new Yield10 Bioscience, Inc. Common Stock positions in Q4 2013 and 5 closed out, a net change of -3 holders.
- The largest Yield10 Bioscience, Inc. Common Stock buyer in Q4 2013 was FCG Advisors, an estimated $402K added.
- The largest Yield10 Bioscience, Inc. Common Stock seller in Q4 2013 was State Farm Mutual Automobile Insurance, an estimated $2.9M sold.
Based on aggregated 13F filings for Q4 2013.